Ballast Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Ballast Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20	Closed	-$528	–	209
2026 Q1	$528	Buy	+20	New	+$586	﹤0.01%	390
2021 Q3	–	Sell	-778	Closed	-$72K	–	178
2021 Q2	$72K	Hold	778	–	–	0.03%	140
2021 Q1	$69K	Buy	+778	New	+$77.2K	0.03%	135

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Ballast Advisors's ARKG Position: Q2 2026 in Review

Ballast Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 20 shares — an estimated $528 sold.

Ballast Advisors first reported a position in ARKG in Q1 2021 and held it in 3 quarters. The position peaked at $72K in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Ballast Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Ballast Advisors sold 20 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $528.
Ballast Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 3 quarters.
Ballast Advisors's ARK Genomic Revolution ETF position peaked at $72K in Q2 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.